AD03

AD03 · Affiris AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD03, covering 2013-11-06 to 2013-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AD03 Applied During AFF005A